Angela B Brueggemann

researcher

Angela B Brueggemann is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-2329-1934

P69educated atUniversity of OxfordQ34433
P108employerUniversity of OxfordQ34433
P734family nameBrueggemannQ36986083
BrueggemannQ36986083
BrueggemannQ36986083
P735given nameAngelaQ4851436
AngelaQ4851436
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q54069105A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions.
Q33980770Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.
Q34737818Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study
Q36605871Antibiotic resistance mechanisms among pediatric respiratory and enteric pathogens: A current update.
Q43458897Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children.
Q33982256Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.
Q37093776Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.
Q54096793Assessment of laboratory performance with Streptococcus pneumoniae antimicrobial susceptibility testing in the United States: a report from the College of American Pathologists Microbiology Proficiency Survey Program.
Q59538951Assessment of the oxacillin disk screening test for determining Penicillin resistance inStreptococcus pneumoniae
Q114655307Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiati
Q59538907Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing
Q46579471Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial
Q59538910Clonal Relationships between Invasive and Carriage Streptococcus pneumoniae and Serotype‐ and Clone‐Specific Differences in Invasive Disease Potential
Q54118620Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.
Q33972226Comparison of results generated by serotyping, pulsed-field restriction analysis, ribotyping, and repetitive-sequence PCR used to characterize penicillin-resistant pneumococci from the United States
Q36933194Correction for van Tonder et al., Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Q34075033Defining the estimated core genome of bacterial populations using a Bayesian decision model
Q47174198Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I-Related Molecule-Dependent and Cytokine-Driven Pathways.
Q59807597Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland
Q35967600Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study
Q33183542Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
Q46987516Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state
Q34860277Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974
Q37641273Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012).
Q34113933Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.
Q58700655Genome Sequencing Reveals a Large and Diverse Repertoire of Antimicrobial Peptides
Q59538871Genome sequencing reveals that Streptococcus pneumoniae possesses a large and diverse repertoire of antimicrobial toxins
Q64104783Genomic Analyses of >3,100 Nasopharyngeal Pneumococci Revealed Significant Differences Between Pneumococci Recovered in Four Different Geographical Regions
Q34487073Genomic analyses of pneumococci reveal a wide diversity of bacteriocins - including pneumocyclicin, a novel circular bacteriocin
Q35757571Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci
Q37058924Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.
Q57970431Heterogeneity Among Estimates Of The Core Genome And Pan-Genome In Different Pneumococcal Populations
Q35137355In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Q59538957In vitro activity of sanfetrinem (GV104326), a new trinem antimicrobial agent, versus Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Q59538943Influence of Triple-Lumen Central Venous Catheters Coated With Chlorhexidine and Silver Sulfadiazine on the Incidence of Catheter-Related Bacteremia
Q43965883Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England
Q43914049Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia
Q59538897Molecular Typing of Pneumococci Causing Parapneumonic Empyema in Spanish Children Using Multilocus Sequence Typing Directly on Pleural Fluid Samples
Q59538891Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine
Q37693513Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review
Q36522997Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.
Q34769475Near patient testing for influenza in children in primary care: comparison with laboratory test
Q59538946Partial Liquid Ventilation with Perfluorocarbon in the Treatment of Rats with Lethal Pneumococcal Pneumonia
Q37015614Pediatric parapneumonic empyema, Spain.
Q36509817Pneumococcal capsular switching: a historical perspective
Q35828374Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
Q37652657Pneumococcal prophages are diverse, but not without structure or history
Q36413948Pneumococci can persistently colonize adult patients with chronic respiratory disease
Q59538885Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005
Q35055346Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
Q48078155Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks
Q54075039Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995.
Q90929675Prophages and satellite prophages are widespread in Streptococcus and may play a role in pneumococcal pathogenesis
Q38764576Putatively novel serotypes and the potential for reduced vaccine effectiveness: capsular locus diversity revealed among 5405 pneumococcal genomes
Q40303528Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study.
Q59538923Roundtable discussion. Optimizing the use of antimicrobial therapy
Q34834011Shifting genetic structure of invasive serotype 19A pneumococci in the United States
Q59538935Simultaneous Respiratory Tract Colonization by Multiple Strains of NontypeableHaemophilus influenzaein Chronic Obstructive Pulmonary Disease: Implications for Antibiotic Therapy
Q39732954Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae
Q33721628Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation
Q59538905Temporal and Geographic Stability of the Serogroup‐Specific Invasive Disease Potential of Streptococcus pneumoniae in Children
Q96946241The Global Meningitis Genome Partnership
Q53983859The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.
Q36633083The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success
Q44920861The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance Program
Q91080546Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland
Q33306103Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
Q34805454Whooping cough in school age children with persistent cough: prospective cohort study in primary care

Search more.